The San Diego 500, The Book of Influential Business Leaders, is the market’s most comprehensive product of people you should know in the business community. The 500 includes business leaders and executives who have founded or are running significant companies in terms of number of jobs, key products and services, experts who raise the level of the industry here and beyond and those who lead in the business community. The 500 is selected by the San Diego Business Journal newsroom.
Executive Partner, Soffinova
David Kabakoff joined Sofinnova as an executive partner in 2007. He represents Sofinnova as the chairman of NextCure. He also serves as the director of Antiva Biosciences, Dauntless Pharmaceuticals, and Principia. He is chairman of Lineagen and a director of bioTheranostics. Earlier in his career, he served as the chairman of Trius Therapeutics and Amplimmune. He was a director of InterMune and Allylix. Kabakoff spent nearly three decades leading technology and product development programs in the areas of pharmaceutical, biopharmaceutical, and drug delivery.
ALMA MATER: Yale University, Case Western Reserve University
SCIENCE SUCCESS: A chemist by trade, as an operator some of his successes include development of the first yes/no color changing pregnancy test, the PSA test for prostate cancer and the rapid strep throat test.